Clinical Research Directory
Browse clinical research sites, groups, and studies.
GENOSS Coronary Stent Clinical Trial
Sponsor: Samsung Medical Center
Summary
This study aims to evaluate the efficacy and safety of abluminal biodegradable polymer ultrathin sirolimus-eluting stent (Genoss stent) as compared with a durable-polymer everolimus-eluting stent (Xience stent) in patients with coronary artery disease.
Official title: Comparison Between Abluminal Biodegradable Polymer Ultrathin Sirolimus-eluting Stent and Durable-polymer Everolimus-eluting Stent (GENOSS Randomized Clinical Trial)
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
850
Start Date
2022-04-24
Completion Date
2027-06-30
Last Updated
2022-07-06
Healthy Volunteers
No
Conditions
Interventions
Implanatation of Genoss DES sirolimus-eluting coronary system
Percutaneous coronary intervention will proceed as per clinical guidelines, under operator's discretion. Genoss stent will be implanted if the lesion is deemed necessary to be revascularized by stenting
Implanatation of Xience DES everolimus-eluting coronary system
Percutaneous coronary intervention will proceed as per clinical guidelines, under operator's discretion. Xience stent will be implanted if the lesion is deemed necessary to be revascularized by stenting
Locations (1)
Cardiac and Vascular Center; Samsung Medical Center
Seoul, South Korea